White Papers

Side Effects of Telemedicine: How COVID-19 is Disrupting Healthcare Licensing

Lorraine Cody is Subject Matter Expert for Licensing at Business Licenses, LLC. Alan Ruttenberg is Marketing Director at Business Licenses, LLC. They recently met (online, appropriately enough) to discuss telemedicine, telehealth, and rapidly evolving licensure issues during the COVID-19 pandemic. Eric Feigenbaum, Director of Business Development at Business Licenses, LLC also had a few thoughts which were added in post facto. The entire conversation has been lightly edited for clarity.

Alan Ruttenberg: Telemedicine, what is it? That’s a surprisingly complicated question.

Lorraine Cody: Here’s what makes it complicated. There’s actually telehealth and telemedicine and there are important distinctions between them. From a legislative point of view, telemedicine is about the diagnosis and treatment of patients using remote communication technology. That’s typically done by doctors and physicians. Meanwhile, telehealth is a broader category that encompasses the work of nurses, pharmacists and other health professionals who work to maintain your overall health. They may work with you to develop a health-related services plan for instance. They can do this through various platforms that are out there and many more that are in the works. The challenge for business license authorities is to catch up with the technology and fit both of these practices into a regulatory structure. I probably over answered your question, but that’s me.

 

The rest of this interview can be downloaded using the form on the right.